PRLD · Prelude Therapeutics Inc · Debt
$3.88
+0.18 (+4.86%)
At close · Oct 27
Return incl. dividend (before tax)
Q3 2025 earnings call transcript
Market Cap
$295.27M
Shares
79.80M
Volume · Oct 27
277.22K
Avg daily vol (3M)
518.04K
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Operating lease liabilities | 2026-06-30 | USD 17,650,000 | 10-Q filed 2026-08-11 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.